Merck: Getting closer to biosimilars markets in Asia and Latin America

September 2015. Emerging economies have challenges of their own. Merck is setting out to follow its peers, but first there are some changes in manufacturing in Switzerland. The first market in Asia is already approached with a business model learned from NGOs and corporate charity donations.Reading time: 1 min

Read Now:
1,00 EUR (incl. 7% VAT)

Back to section